AstriVax

AstriVax

Aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
$132—198m (Dealroom.co estimates Aug 2022.)
Company register number 0787.990.881
Leuven Flemish Brabant (HQ & founding location)
Authorizing premium user...